
Jeffrey S Sager MD MSc
Critical Care Medicine, Pulmonary Vascular Medicine
Jeffrey S Sager MD Medical Corporation
Join to View Full Profile
2428 Castillo StreetSuite DSanta Barbara, CA 93105
Phone+1 805-845-1500
Fax+1 805-845-0333
Dr. Sager is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jeffrey Sager is a pulmonologist based in Santa Barbara, CA, with subspecialties in Critical Care Medicine and Pulmonary Vascular Medicine. He completed his fellowship in Pulmonary Disease and Critical Care Medicine at the University of Pennsylvania and holds an MSc in Clinical Epidemiology and Biostatistics. Dr. Sager has served in various roles, including Director at Cottage Health System and as a provider at his medical corporation. His clinical expertise includes chronic obstructive pulmonary disease, bronchoscopy, pulmonary arterial hypertension, and sleep apnea. He has contributed to research published in renowned journals focusing on pulmonary hypertension and participated in multiple clinical trials related to pulmonary arterial hypertension. Dr. Sager was named a Top Doctor in the LA Area by Castle Connolly
Education & Training
University of PennsylvaniaMSc, Clinical Epidemiology and Biostatistics , 2003 - 2005
University of Pennsylvania Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 2001 - 2004
Albert Einstein Healthcare NetworkResidency, Internal Medicine, 1998 - 2000
University of the WitwatersrandClass of 1995
Certifications & Licensure
CA State Medical License 2007 - 2027
PA State Medical License 1997 - 2008
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Care360 EHR, MedPlus, A Quest Diagnostics Company, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Care360 EHR, Quest Diagnostics Incorporated, 2012, 2014, 2016-2017
- Top Doctors:LA Area Castle Connolly, 2013
Clinical Trials
- Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension Start of enrollment: 2008 May 01
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis Start of enrollment: 2009 Jul 01
- Ventavis® Registry Protocol
Publications & Presentations
PubMed
- 1 citationsMedication Nonadherence in Patients with Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry (PHAR).Eric W Robbins, Kaitlin Bradley, David Badesch, Charles Burger, Amy M Chyboski
Annals of the American Thoracic Society. 2025-06-01 - 16 citationsPulmonary artery compliance in different forms of pulmonary hypertension.Amber McCormick, Amita Krishnan, David Badesch, Raymond L Benza, Todd M Bull
Heart. 2023-06-26 - 1 citationsImpact of the COVID-19 pandemic on chronic disease management and patient reported outcomes in patients with pulmonary hypertension: The Pulmonary Hypertension Associa...Megan Mayer, David B Badesch, Kelly H Nielsen, Steven Kawut, Todd Bull
Pulmonary Circulation. 2023-04-01
Press Mentions
Triple and Double Therapy Prove Equal for PAHSeptember 28th, 2021
Professional Memberships
- Fellow
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









